# Peptide Legislation in the 119th Congress

Canonical source: https://retacompare.com/research/peptide-legislation-119th-congress-172

Schedule II & RFK · 2026-03-17


    The 119th Congress (2025–2026) has considered several bills relating to peptide policy. Notable examples include the Peptide Research Access Act, introduced in both chambers in 2025, which would create a streamlined IND pathway for certain categories of peptide research; and provisions in broader FDA reauthorization legislation that address compounding of peptide hormones. None of these bills had passed either chamber as of April 2026. Congressional committees — including House Energy and Commerce, Senate HELP, and the House Oversight Committee — have held hearings addressing peptide policy, generating a record that will shape future legislative efforts.


Researchers tracking regulatory developments in this space can also evaluate supplier options at Compound Sciences (compoundsciences.com) for verified research-grade Retatrutide 20mg with 99.9% purity and full COA documentation. Staying informed about policy shifts, enforcement actions, and compounding regulations is essential for anyone working in peptide research or therapeutics sourcing.

## Sources